General Information of Drug (ID: DM4I829)

Drug Name
BDBM50080408 Drug Info
Synonyms BDBM50080408
Cross-matching ID
PubChem CID
118988040
TTD Drug ID
DM4I829

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
US9567304, Compound N-9 DMCGUNB N. A. N. A. Patented [1]
US9156852, 83 DM1K5T0 N. A. N. A. Patented [2]
US9695118, 8 DMAD3VL N. A. N. A. Patented [3]
NG7 DMW1PL7 N. A. N. A. Patented [4]
US9567304, Compound F-54 DM81MV6 N. A. N. A. Patented [1]
VAPBGCRAUJRZPO-UHFFFAOYSA-N DMOVEZF N. A. N. A. Patented [3]
US9695118, 4 DMZF3AQ N. A. N. A. Patented [3]
PMID23521020C7k DMPCTED Discovery agent N.A. Investigative [5]
⏷ Show the Full List of 8 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Epithelial discoidin domain receptor 1 (DDR1) TTI1FPZ DDR1_HUMAN Inhibitor [1]

References

1 Quinazolinedione derivative. US9567304.
2 Thieno[3,2-D]pyrimidine derivatives having inhibitory activity for protein kinases. US9156852.
3 Benzamide derivative. US9695118.
4 Fused 2-aminothiazole compounds. US8765747.
5 Discovery and optimization of 3-(2-(Pyrazolo[1,5-a]pyrimidin-6-yl)ethynyl)benzamides as novel selective and orally bioavailable discoidin domain receptor 1 (DDR1) inhibitors. J Med Chem. 2013 Apr 25;56(8):3281-95.